Assess Immunogenicity, Reactogenicity, Safety of a Booster of GSK Biologicals DTPw-HBV/Hib Kft Compared to DTPw-HBV/Hib

Clinical trial NCT00332566 · COMPLETED

Trial details

NCT number: NCT00332566
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hepatitis B Whole Cell Pertussis Tetanus Haemophilus Influenzae Type b Diphtheria

Start date: 2006-06-01
Primary completion: 2006-10-01
Enrollment: 148

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.